IMNN
Imunon, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.99
−3.43%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-351.3%
Return on equity
-98.2%
Return on assets
-123.3%
Return on invested capital
0.00x
Asset turnover
-$4.0B
Cash from operations
$1.22
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026